title: Cardiovascular PET-CT imaging: a new frontier?
abstract: Cardiovascular positron-emission tomography combined with computed tomography (PET-CT) has recently emerged as an imaging technology with the potential to simultaneously describe both anatomical structures and physiological processes in vivo. The scope for clinical application of this technique is vast, but to date this promise has not been realised. Nonetheless, significant research activity is underway to explore these possibilities and it is likely that the knowledge gained will have important diagnostic and therapeutic implications in due course. This review provides a brief overview of the current state of cardiovascular PET-CT and the likely direction of future developments.
authors.affiliation: Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK. Electronic address: philip.adamson@ed.ac.uk.
authors.forename: P D
authors.initials: PD
authors.lastname: Adamson
authors.affiliation: Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK.
authors.forename: M C
authors.initials: MC
authors.lastname: Williams
authors.affiliation: Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK.
authors.forename: D E
authors.initials: DE
authors.lastname: Newby
mesh_terms: D002318:Cardiovascular Diseases / Q000000981:diagnostic imaging*; D019788:Fluorodeoxyglucose F18; D005544:Forecasting; D006334:Heart Function Tests / Q000379:methods* / Q000639:trends*; D006801:Humans; D007089:Image Enhancement / Q000379:methods; D000072078:Positron Emission Tomography Computed Tomography / Q000379:methods* / Q000639:trends*; D019275:Radiopharmaceuticals; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity
chemical_list: D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18